Industry2d ago
Isomorphic Labs Raises $2.1 Billion For Drug Discovery
A $2.1 billion funding round fuels Isomorphic Labs as it scales its Drug Design Engine. The Google DeepMind spin-off partnered with Novartis and Eli Lilly to identify hidden drug targets. This approach leverages protein structure prediction to bypass traditional discovery bottlenecks. Practitioners gain a concrete example of AI moving from research to clinical pipelines.